Reply to ‘Biosimilars: A Position Paper of the European Society for Medical Oncology, With Particular Reference to Oncology Prescribers’

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2017-000281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy